Cargando…

Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

Detalles Bibliográficos
Autores principales:	Hioe, Catarina E., Liu, Xiaomei, Banin, Andrew N., Heindel, Daniel W., Klingler, Je´romine, Rao, Priyanka G., Luo, Christina C., Jiang, Xunqing, Pandey, Shilpi, Ordonez, Tracy, Barnette, Philip, Totrov, Maxim, Zhu, Jiang, Na´das, Arthur, Zolla-Pazner, Susan, Upadhyay, Chitra, Shen, Xiaoying, Kong, Xiang-Peng, Hessell, Ann J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666736/ https://www.ncbi.nlm.nih.gov/pubmed/38022586 http://dx.doi.org/10.3389/fimmu.2023.1329069

Ejemplares similares

Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
por: Hioe, Catarina E., et al.
Publicado: (2023)

Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
por: Upadhyay, Chitra, et al.
Publicado: (2018)

Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies
por: Shen, Guomiao, et al.
Publicado: (2015)

Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
por: Hioe, Catarina E., et al.
Publicado: (2018)

Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice
por: Hioe, Catarina E., et al.
Publicado: (2022)

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
por: Weiss, Svenja, et al.
Publicado: (2022)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
por: Balasubramanian, Preetha, et al.
Publicado: (2018)

Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens
por: Chiu, Y, et al.
Publicado: (2012)

Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure
por: Gorny, Miroslaw K., et al.
Publicado: (2011)

Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients
por: Klingler, Jéromine, et al.
Publicado: (2022)

Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes
por: Upadhyay, Chitra, et al.
Publicado: (2020)

HIV-1 Envelope Glycan Composition as a Key Determinant of Efficient Virus Transmission via DC-SIGN and Resistance to Inhibitory Lectins
por: Jan, Muzafar, et al.
Publicado: (2019)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

A HIGH THROUGH-PUT ASSAY FOR CIRCULATING ANTIBODIES DIRECTED AGAINST THE S PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
por: Weiss, Svenja, et al.
Publicado: (2020)

P12-13. Structure-guided design and immunological characterization of immunogen constructs presenting the HIV-1 gp120 V3 loop on a CTB scaffold
por: Totrov, M, et al.
Publicado: (2009)

A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
por: Weiss, Svenja, et al.
Publicado: (2020)

Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
por: Hioe, Catarina E., et al.
Publicado: (2010)

Complement contributes to antibody-mediated protection against repeated SHIV challenge
por: Goldberg, Benjamin S., et al.
Publicado: (2023)

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins
por: Jan, Muzafar, et al.
Publicado: (2018)

Identifying epitopes of HIV-1 that induce protective antibodies
por: Zolla-Pazner, Susan
Publicado: (2004)

Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes
por: Fox, Alisa, et al.
Publicado: (2022)

Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
por: Zolla-Pazner, Susan, et al.
Publicado: (2015)

P04-42. Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crown
por: Jiang, X, et al.
Publicado: (2009)

Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
por: Spencer, David A., et al.
Publicado: (2022)

Immunoprophylaxis against Mother-to-Child Transmission of HIV-1
por: Gorny, Miroslaw K, et al.
Publicado: (2006)

P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
por: Swetnam, J, et al.
Publicado: (2009)

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
por: Mayr, Luzia M., et al.
Publicado: (2017)

Ligand binding site superposition and comparison based on Atomic Property Fields: identification of distant homologues, convergent evolution and PDB-wide clustering of binding sites
por: Totrov, Maxim
Publicado: (2011)

Estimated Secondary Structure Propensities within V1/V2 Region of HIV gp120 Are an Important Global Antibody Neutralization Sensitivity Determinant
por: Totrov, Maxim
Publicado: (2014)

Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates
por: Rosenberg, Yvonne J., et al.
Publicado: (2023)

Residue 315 regulates V3 exposure and V3 antibody recognition on HIV subtype B and C viruses
por: Manhas, S, et al.
Publicado: (2012)

Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes
por: Swetnam, James, et al.
Publicado: (2010)

P19-21. Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone
por: Almond, D, et al.
Publicado: (2009)

Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
por: Zolla-Pazner, Susan, et al.
Publicado: (2019)

Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies
por: Almond, David, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4nvrqeu53ivkci938uvb1jp4r0